Viz.ai is a first-of-its-kind, AI-powered workflow company. Viz.ai uses artificial intelligence to find suspected aortic dissection, pulmonary embolism, ischemic stroke, and hemorrhagic stroke. We are the first and only FDA-approved platform to do so. Viz.ai alerts your team of suspected disease within a few minutes of CT completion. The platform includes the full imaging study in your pocket, built-in HIPAA-compliant chat, the on-call team directory, and critical patient information. This enables you and your team to make treatment decisions quickly and easily. Independent researchers of the technology have published increased efficiency of care and significant improvements to patient outcomes in stroke. Viz.ai is currently installed in over 850 hospitals and growing.
ACC.22 Learning Pathways? (select all that apply) Multimodality Imaging, Pulmonary Vascular Disease, Vascular Medicine